• Home
  •  / Kedalion Therapeutics

Kedalion Therapeutics

OverviewSuggest Edit

Kedalion Therapeutics is an ophthalmic drug company focused on the delivery of ocular medicines. Its AcuStream technology delivers topical drugs to the eye enabling comparable therapy with a reduction in dose relative to standard drops.
TypePrivate
Founded2015
HQMenlo Park, CA, USMap
Websitekedalionthera.com

Locations

Kedalion Therapeutics is headquartered in
Menlo Park, United States

Location Map
All Locations (1)

Latest Updates

Employees (est.) (Jan 2021)6
Cybersecurity ratingAMore

Key People/Management at Kedalion Therapeutics

Ehud Ivri

Ehud Ivri

Chief Technology Officer & Co-Founder
Mark Blumenkranz

Mark Blumenkranz

Chairman, Chief Executive Officer & Co-Founder
Mark Murray

Mark Murray

Chief Financial Officer
Reynaldo Quintana

Reynaldo Quintana

Senior Vice President, Research and Development
Joseph Gilbert

Joseph Gilbert

Director, Clinical Operations
Casey Dougan

Casey Dougan

Chief Operating Officer and Executive Vice President
Show more

Kedalion Therapeutics Office Locations

Kedalion Therapeutics has an office in Menlo Park
Menlo Park, CA, US (HQ)
1490 O'Brien Dr suite c
Show all (1)

Kedalion Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2015

Kedalion Therapeutics total Funding

$5 m

Kedalion Therapeutics latest funding size

$5 m

Time since last funding

2 years ago

Kedalion Therapeutics investors

Lagunita BioSciences LLC
Kedalion Therapeutics's latest funding round in August 2018 was reported to be $5 m. In total, Kedalion Therapeutics has raised $5 m
Show all financial metrics

Kedalion Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

Learn more about our premium products
SecurityScorecard logo

Kedalion Therapeutics Online and Social Media Presence

Kedalion Therapeutics's Trends

Embed Graph

 Kedalion Therapeutics Frequently Asked Questions

  • When was Kedalion Therapeutics founded?

    Kedalion Therapeutics was founded in 2015.

  • Who are Kedalion Therapeutics key executives?

    Kedalion Therapeutics's key executives are Ehud Ivri, Mark Blumenkranz and Mark Murray.

  • How many employees does Kedalion Therapeutics have?

    Kedalion Therapeutics has 6 employees.

  • Who are Kedalion Therapeutics competitors?

    Competitors of Kedalion Therapeutics include Elysia, CooperSurgical and MedMinder.

  • Where is Kedalion Therapeutics headquarters?

    Kedalion Therapeutics headquarters is located at 1490 O'Brien Dr suite c, Menlo Park.

  • Where are Kedalion Therapeutics offices?

    Kedalion Therapeutics has an office in Menlo Park.

  • How many offices does Kedalion Therapeutics have?

    Kedalion Therapeutics has 1 office.